No Detail Found!

Clinical and laboratory characteristics of COVID-19 infection in patients presenting to a tertiary care hospital

Author(s)
Huma Batool Lahore General Hospital, Lahore, Pakistan
Asifa Karamat Lahore General Hospital, Lahore, Pakistan
Khalid Waheed Lahore General Hospital, Lahore, Pakistan
Sohail Anwar Lahore General Hospital, Lahore, Pakistan
Syed Arslan Haider Lahore General Hospital, Lahore, Pakistan
Syed Mazhar Ali Naqvi Lahore General Hospital, Lahore, Pakistan
Munaza Javed Lahore General Hospital, Lahore, Pakistan
Abstract
COVID-19 disease is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) having a wide variety of clinical features ranging from asymptomatic carriers to respiratory failure requiring mechanical ventilation. The objective of the study was to analyze the spectrum of diefrent symptoms, laboratory findings, and complications in patients who were admietd in either COVID ward or intensive care unit (ICU) of a local hospital. Methods: A retrospecvtie cohort study of the medical records of 100 COVID-19 disease paetints with polymerase chain reacotin (PCR) detected SARS-CoV-2 infecotin were collected. Parctiipant informaotin was retrospecvtiely obtained from the hospital medical records which included clinical records and laboratory nfidings. All stastictial analyses were done using Stastictial Package for the Social Sciences version 21. Results: The mean age of the patients was 50.8 ± 5.86 with male predominance (79%). Most frequent co-morbidities were diabetes mellitus (42%) and hypertension (36%). Most frequent symptoms were fever (95.9%) and fatigue (95.9%) followed by dry cough (86.5%), myalgia (85.1), and shortness of breath (70%). Amongst the patients admietd, leukocyte count was 10.95 × 10 3, C-reactive protein was 12.8 mg/dl, ferritin was 730.8 ng/ml, and lactate dehydrogenase was found to be 1,254.7 U/l. Hepatic and renal functions were borderline deranged. Conclusion: COVID-19 disease has a wide spectrum of clinical symptoms. Patients with raised inflammatory markers have severe disease and are more likely in need of an ICU care. By carefully observing these markers may help in beetr management of COVID-19 disease.
Publication Details
Page(s) 179-184
Published Journal: Biomedica, Volume: 37, Issue: 3, Year: 2021

Request the full text from PASTIC

Keywords
Laboratory markers, COVID-19, Complications, COVID-19, Intensive Care Unit, Coronavirus, Covid-19
References
Hiscott J,Alexandridi M,Muscolini M,Tassone E,Palermo E,Soultsioti M .2020 .The global impact of the coronavirus pandemic. Cytokine Growth Factor Rev, 05(4) : 1-9.
Cascella M,Rajnik M,Cuomo A,Dulebohn SC,Di Napoli R. Features SC .2021 .cited 2021 Sep]. Treasure Island, : .
Jamwal A,Bhatnagar S,Sharma P .2020 .cited 2021 Mar]. , : .
Wu Z,McGoogan JM .2020 .Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA, 323(13) : 1239-42.
Li Q,Guan X,Wu P,Wang X,Zhou L,Tong Y .2020 .Early transmission dynamics in Wuhan, China, of novel coronavirusinfected pneumonia. N Engl J Med, 382(13) : 1199-207.
Shi H,Han X,Jiang N,Cao Y,Alwalid O,Gu J .2020 .Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis, 3099(20) : 30086-4.
Liu K,Fang YY,Deng Y,Liu W,Wang MF,Ma JP .2020 .Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med, 133(9) : 1025-31.
Wang D,Hu B,Hu C,Zhu F,Liu X,Zhang J .2020 .Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. , 323(11) : 1061-9.
Fang L,Karakiulakis G,Roth M. .2020 .Are patients with hypertension and diabetes mellitus at increased risk for COVID-. infection? Lancet Respir Med, 2600(20) : 30116-8.
Fan BE .2020 .Hematologic parameters in patients with COVID-19 infection: a reply. Am. J Hematol, 95(8) : e213-5.
Guan WJ,Ni ZY,Hu Y,Liang WH,Ou CQ,He JX .2020 .Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med, 382(18) : 1708-20.
Al Ghamdi M,Alghamdi KM,Ghandoora Y,Alzahrani A,Salah F,Alsulami A .2016 .Treatment outcomes for patients with middle eastern respiratory syndrome coronavirus (MERS CoV) infection at a coronavirus referral center in the Kingdom of Saudi Arabia. BMC Infect, 16(1) : 1-7.
Wang JT,Sheng WH,Fang CT,Chen YC,Wang JL,Yu CJ .2004 .Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients. Emerg Infect Dis, 10(5) : 818-24.
Grasselli G,Zangrillo A,Zanella A,Antonelli M,Cabrini L,Castelli A .2020 .Baseline characteristics and outcomes of 1,591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. , 323(16) : 1574-81.
Gupta S,Hayek SS,Wang W,Chan L,Mathews KS,Melamed ML .2020 .Factors associated with death in critically ill patients with coronavirus disease 2019 in the US. JAMA Intern Med, 180(11) : 1436-46.
Asghar MS,Kazmi SJ,Khan NA,Akram M,Khan SA,Rasheed U .2020 .Clinical profiles, characteristics, and outcomes of the first 100 admitted COVID-19 patients in Pakistan: a single-center retrospective study in a tertiary care hospital of Karachi. , 12(6) : e8712-41.
Hong KH,Choi JP,Hong SH,Lee J,Kwon JS,Kim SM .2018 .Predictors of mortality in middle east respiratory syndrome (MERS). -209313, 73(3) : 286-9.
Chen N,Zhou M,Dong X,Qu J,Gong F,Han Y .2020 .Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 6736(20) : 30211-7.
Paudel SS .2020 .cited 2021 Aug]. , 21831 : .
Thomas RL,Halim S,Gurudas S,Sivaprasad S,Owens DR .2019 .IDF diabetes Atlas: a review of studies utilising retinal photography on the global prevalence of diabetes related retinopathy between 2015 and 2018. Diabetes Res Clin Pract, 157 : 107840-53.
Zhang JJ,Dong X,Cao YY,Yuan YD,Yang YB,Yan YQ .2020 .Clinical characteristics of 140 patients infected with SARSCoV-2 in Wuhan, China. , 75(7) : 1730-41.
Liu J,Liu Y,Xiang P,Pu L,Xiong H,Li C .2020 .cited 2021 Jul]. MedRxiv, : .
Omrani-Nava V,Maleki I,Ahmadi A,Moosazadeh M,Hedayatizadeh-Omran A,Roozbeh F .2020 .Evaluation of hepatic enzymes changes and association with prognosis in COVID-19 patients. Hepat Mon, 20(4) : .
Vakili K,Fathi M,Pezeshgi A,Mohamadkhani A,Hajiesmaeili M,Rezaei-Tavirani M .2020 .Critical complications of COVID19: a descriptive meta-analysis study. Rev Cardiovasc Med, 03(3) : 433-42.
Moores LK,Tritschler T,Brosnahan S,Carrier M,Collen JF,Doerschug K .2020 .Prevention, diagnosis, and treatment of VTE in patients with coronavirus disease 2019: CHEST guideline and expert panel report. Chest, 05(3) : 1143-63.
Gomes C .2020 .Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19). Braz J Implantol Health Sci, 2(3) : 1.
Ahmad Q,DePerrior SE,Dodani S,Edwards JF,Marik PE .2020 .Role of inflammatory biomarkers in the prediction of ICU admission and mortality in patients with. COVID-19. Med Res Arch, 8(12) : 2307-10.
Chen W,Zheng KI,Liu S,Yan Z,Xu C .2020 .Qiao Z. Plasma CRP level is positively associated with the severity of COVID-19. , 19(18) : 1-7.
0

Citations

0

Downloads

15

Views